In a murine model of dietary obesity, we found that a DPP-4 inhibitor (linagliptin) suppresses capillary rarefaction in cardiac tissue and promotes favorable metabolic remodeling, characterized by elevated levels of citrulline and creatine. Here, DPP4 is linked to Obesity.